ARCHIVES

CCOPs Extended One Year While Waiting Evaluation

This article is from The Cancer Letter archive.

Vol. 11 No. 20 | May 17, 1985

Download PDF Visit The Full Archive

Related Articles

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz

March 29, 2013

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986